ENTROPY NEURODYNAMICS LIMITED (ENP)
AI Coverage Rating: Active
ASX AI Signals has generated 5 signal for ENP during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest ENP Signals | |
| 30/06/2026 | SELL |
| 18/05/2026 | BUY |
| 17/05/2026 | BUY |
ENP Share Price | |
| Current Price | $0.032 |
| 52 Week High | $0.044 |
| 52 Week Low: | $0.027 |
| Trading at (% of 52 Week High) | 72.73% |
Business Overview
Entropy Neurodynamics Limited (ASX: ENP) is an Australian company specializing in developing advanced neurotechnology solutions. The company focuses on creating wearable devices that monitor and analyze brain activity to improve health and wellbeing.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The SELL recommendation for ENTROPY NEURODYNAMICS LIMITED (ENP) is supported by weak price performance and potential liquidity concerns at the current low price level. However, limited publicly available financial data and market activity introduce some uncertainty, moderating the confidence level.
Latest ENTROPY NEURODYNAMICS LIMITED(ENP) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial